Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $655.8200 (1.8%) ($655.8200 - $655.8200) on Mon. Mar. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.59% (three month average) | RSI | 76 | Latest Price | $655.8200(1.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.2% a day on average for past five trading days. | Weekly Trend | REGN advances 1.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(57%) DIA(41%) XLV(40%) IWD(39%) SPY(38%) | Factors Impacting REGN price | REGN will decline at least -0.795% in a week (0% probabilities). VIXM(-19%) TBT(-10%) UUP(-8%) VXX(-3%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.795% (StdDev 1.59%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $633.64(3.5%) | 10 Day Moving Average | $624.92(4.94%) | 20 Day Moving Average | $621.68(5.49%) | To recent high | -2.2% | To recent low | 10.2% | Market Cap | $69.536b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |